Burshtein, Joshua http://orcid.org/0000-0002-9851-088X
Shah, Milaan
Zakria, Danny
Lockshin, Benjamin
Crowley, Jeff
Merola, Joseph F.
Gordon, Ken
Shahriari, Mona
Korman, Neil J.
Chovatiya, Raj
Kalb, Robert
Lebwohl, Mark
Funding for this research was provided by:
UCB Pharma
Article History
Received: 6 November 2023
Accepted: 12 January 2024
First Online: 10 February 2024
Declarations
:
: Benjamin Lockshin has served as an advisor, speaker, and/or investigator for Abbvie, Novartis, Eli Lilly, Sanofi, Regerneron, Incyte, Leo, UCB, Strata Skin Sciences, Arcutis, Dermavant, BMS, Dermtech, and as a consultant for Abbvie, Novartis, Eli Lilly, DermTech, Strata Skin Sciences, CorEvitas Registry, Leo, UCB, Boehringer Ingelheim, Dermavant, BMS, Regeneron, Sanofi. Investigator for Abbvie, Novartis, Eli Lilly, Sanofi, Regerneron, Leo, Pfizer, Franklin Bioscience, Trevi Therapeutics, Inc., Vanda, Celgene, Strata Skin Sciences, Galderma, Amgen, Dermira, and Castle. Jeff Crowley has served as consultant, speaker, and investigator for Abbvie, Lilly, Janssen, Regeneron, Sanofi, UCB, Boerhinger Ingelheim, Bristol Myers Squibb, and Arcutis. Joseph F. Merola is a consultant and/or investigator for Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Abbvie, Dermavant, Eli Lilly, Incyte, Novartis, Janssen, UCB, Sanofi-Regeneron, Sun Pharma, Biogen, Pfizer and Leo Pharma. Ken Gordon has received honoraria and/or research support from AbbVie, Amgen, BMS, Boehringer Ingelheim, Dermavant, Dice, Eli Lilly, Incyte, Janssen, Novartis, MoonLake, Pfizer, Protagonist, UCB, Union. Mona Shahriari has served as an advisor, consultant, speaker, and/or investigator for AbbVie, Arcutis, Bristol Myers Squibb, Dermavant, Janssen, Leo Pharma, Lilly USA, Novartis, Ortho Dermatologics, Sanofi-Genzyme, Regeneron, UCB, Pfizer, CorEvitas Psoriasis Registry, Dermira, Cara, Union, and Mindera. Neil J. Korman has served as an advisor, consultant, speaker, or investigator for: AbbVie, Abcentra, Amgen, Argenx, Astrazeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Castle Bioscience, Celgene, Chemocentryx, Dermavant, Eli Lilly, Galderma, Incyte, Janssen, Kyowa Hakko Kirin Pharma, Leo Pharma, Menlo Therapeutics, Novartis, Olix, Pfizer, Principia, Regeneron, Sun Pharma, Trevi, UCB, XBiotech. Raj Chovatiya has served as an advisor, consultant, speaker, and/or investigator for AbbVie, Apogee Therapeutics, Arcutis, Argenx, ASLAN Pharmaceuticals, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, FIDE, Galderma, Genentech, GSK, Incyte, Janssen, LEO Pharma, L’Oréal, Nektar Therapeutics, Opsidio, Pfizer Inc., Regeneron, RAPT, Sanofi, and UCB. Robert Kalb has received research funding from AbbVie, Amgen, CorEvitas LLC, Janssen Ortho Inc, UCB and the University of Pennsylvania. He has been on the data safety monitoring board for studies with Eli Lilly and the pharmaceutical product development group. He has been a consult for Janssen Ortho and UCB. These grants are paid to his institution. Mark Lebwohl is an employee of Mount Sinai and receives research funds from: Abbvie, Amgen, Arcutis, Avotres, Boehringer Ingelheim, Cara therapeutics, Dermavant Sciences, Eli Lilly, Incyte, Inozyme, Janssen Research & Development, LLC, Ortho Dermatologics, Pfizer, Sanofi-Regeneron, and UCB, Inc., and is a consultant for Almirall, AltruBio Inc., AnaptysBio, Apogee, Arcutis, Inc., AstraZeneca, Atomwise, Avotres Therapeutics, Brickell Biotech, Boehringer-Ingelheim, Bristol-Myers Squibb, Castle Biosciences, Celltrion, Corevitas, Dermavant Sciences, EPI, Evommune, Inc., Facilitation of International Dermatology Education,Forte biosciences, Foundation for Research and Education in Dermatology, Galderma, Genentech, Incyte, LEO Pharma, Meiji Seika Pharma, Mindera, Pfizer, Sanofi-Regeneron, Seanergy, Strata, Takeda, Trevi, and Verrica. Joshua Burshtein, Milaan Shah and Danny Zakria have nothing to disclose.
: All panel experts involved in the study are authors of the manuscript and were informed of the study’s objectives. All of the experts support the submission of this manuscript to a peer-reviewed journal.